Facilitating collaborations to develop combination investigational cancer therapies: workshop summary
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
©2012
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C. Includes bibliographical references (pages 97-99) "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms |
| Beschreibung: | 1 Online-Ressource (xiii, 103 pages) |
| ISBN: | 9780309220651 0309220653 1280123346 9781280123344 9780309220644 0309220645 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042794605 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150902s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 9780309220651 |9 978-0-309-22065-1 | ||
| 020 | |a 0309220653 |9 0-309-22065-3 | ||
| 020 | |a 1280123346 |9 1-280-12334-6 | ||
| 020 | |a 9781280123344 |9 978-1-280-12334-4 | ||
| 020 | |a 9780309220644 |9 978-0-309-22064-4 | ||
| 020 | |a 0309220645 |9 0-309-22064-5 | ||
| 035 | |a (OCoLC)785373830 | ||
| 035 | |a (DE-599)BVBBV042794605 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99/405 |2 23 | |
| 110 | 2 | |a National Cancer Policy Forum (U.S.) |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Facilitating collaborations to develop combination investigational cancer therapies |b workshop summary |c Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c ©2012 | |
| 300 | |a 1 Online-Ressource (xiii, 103 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C. | ||
| 500 | |a Includes bibliographical references (pages 97-99) | ||
| 500 | |a "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description | ||
| 500 | |a Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms | ||
| 650 | 4 | |a Neoplasms / drug therapy / United States / Congresses | |
| 650 | 4 | |a Drug Therapy, Combination / United States / Congresses | |
| 650 | 4 | |a Antineoplastic Agents / therapeutic use / United States / Congresses | |
| 650 | 4 | |a Cooperative Behavior / United States / Congresses | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a Cancer / Prevention |2 fast | |
| 650 | 7 | |a Cancer / Research |2 fast | |
| 650 | 7 | |a Cancer / Treatment |2 fast | |
| 650 | 7 | |a Health planning |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cancer |x Research |z United States |v Congresses | |
| 650 | 4 | |a Cancer |x Treatment |v Congresses | |
| 650 | 4 | |a Cancer |z United States |x Prevention |v Congresses | |
| 650 | 4 | |a Health planning |z United States |v Congresses | |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Patlak, Margie |e Sonstige |4 oth | |
| 700 | 1 | |a Nass, Sharyl J. |e Sonstige |4 oth | |
| 700 | 1 | |a Balogh, Erin |e Sonstige |4 oth | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Board on Health Care Services |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444959 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA |a ZDB-4-NLEBK | ||
| 940 | 1 | |q FAW_PDA_EBA | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028224378 | ||
Datensatz im Suchindex
| _version_ | 1804175028413005824 |
|---|---|
| any_adam_object | |
| author_corporate | National Cancer Policy Forum (U.S.) |
| author_corporate_role | aut |
| author_facet | National Cancer Policy Forum (U.S.) |
| author_sort | National Cancer Policy Forum (U.S.) |
| building | Verbundindex |
| bvnumber | BV042794605 |
| collection | ZDB-4-EBA ZDB-4-NLEBK |
| ctrlnum | (OCoLC)785373830 (DE-599)BVBBV042794605 |
| dewey-full | 616.99/405 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/405 |
| dewey-search | 616.99/405 |
| dewey-sort | 3616.99 3405 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03963nmm a2200673zc 4500</leader><controlfield tag="001">BV042794605</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150902s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309220651</subfield><subfield code="9">978-0-309-22065-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309220653</subfield><subfield code="9">0-309-22065-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280123346</subfield><subfield code="9">1-280-12334-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280123344</subfield><subfield code="9">978-1-280-12334-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309220644</subfield><subfield code="9">978-0-309-22064-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309220645</subfield><subfield code="9">0-309-22064-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)785373830</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042794605</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/405</subfield><subfield code="2">23</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Facilitating collaborations to develop combination investigational cancer therapies</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">©2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 103 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 97-99)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Therapy, Combination / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents / therapeutic use / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cooperative Behavior / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Prevention</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Health planning</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="z">United States</subfield><subfield code="x">Prevention</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health planning</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balogh, Erin</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Board on Health Care Services</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444959</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028224378</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV042794605 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:09:46Z |
| institution | BVB |
| isbn | 9780309220651 0309220653 1280123346 9781280123344 9780309220644 0309220645 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028224378 |
| oclc_num | 785373830 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiii, 103 pages) |
| psigel | ZDB-4-EBA ZDB-4-NLEBK FAW_PDA_EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | National Cancer Policy Forum (U.S.) Verfasser aut Facilitating collaborations to develop combination investigational cancer therapies workshop summary Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies Washington, D.C. National Academies Press ©2012 1 Online-Ressource (xiii, 103 pages) txt rdacontent c rdamedia cr rdacarrier Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C. Includes bibliographical references (pages 97-99) "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms Neoplasms / drug therapy / United States / Congresses Drug Therapy, Combination / United States / Congresses Antineoplastic Agents / therapeutic use / United States / Congresses Cooperative Behavior / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Cancer / Prevention fast Cancer / Research fast Cancer / Treatment fast Health planning fast Medizin Cancer Research United States Congresses Cancer Treatment Congresses Cancer United States Prevention Congresses Health planning United States Congresses USA (DE-588)1071861417 Konferenzschrift gnd-content Patlak, Margie Sonstige oth Nass, Sharyl J. Sonstige oth Balogh, Erin Sonstige oth National Cancer Policy Forum (U.S.) Sonstige oth Institute of Medicine (U.S.) Board on Health Care Services Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444959 Aggregator Volltext |
| spellingShingle | Facilitating collaborations to develop combination investigational cancer therapies workshop summary Neoplasms / drug therapy / United States / Congresses Drug Therapy, Combination / United States / Congresses Antineoplastic Agents / therapeutic use / United States / Congresses Cooperative Behavior / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Cancer / Prevention fast Cancer / Research fast Cancer / Treatment fast Health planning fast Medizin Cancer Research United States Congresses Cancer Treatment Congresses Cancer United States Prevention Congresses Health planning United States Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Facilitating collaborations to develop combination investigational cancer therapies workshop summary |
| title_auth | Facilitating collaborations to develop combination investigational cancer therapies workshop summary |
| title_exact_search | Facilitating collaborations to develop combination investigational cancer therapies workshop summary |
| title_full | Facilitating collaborations to develop combination investigational cancer therapies workshop summary Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_fullStr | Facilitating collaborations to develop combination investigational cancer therapies workshop summary Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_full_unstemmed | Facilitating collaborations to develop combination investigational cancer therapies workshop summary Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_short | Facilitating collaborations to develop combination investigational cancer therapies |
| title_sort | facilitating collaborations to develop combination investigational cancer therapies workshop summary |
| title_sub | workshop summary |
| topic | Neoplasms / drug therapy / United States / Congresses Drug Therapy, Combination / United States / Congresses Antineoplastic Agents / therapeutic use / United States / Congresses Cooperative Behavior / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Cancer / Prevention fast Cancer / Research fast Cancer / Treatment fast Health planning fast Medizin Cancer Research United States Congresses Cancer Treatment Congresses Cancer United States Prevention Congresses Health planning United States Congresses |
| topic_facet | Neoplasms / drug therapy / United States / Congresses Drug Therapy, Combination / United States / Congresses Antineoplastic Agents / therapeutic use / United States / Congresses Cooperative Behavior / United States / Congresses HEALTH & FITNESS / Diseases / Cancer MEDICAL / Oncology Cancer / Prevention Cancer / Research Cancer / Treatment Health planning Medizin Cancer Research United States Congresses Cancer Treatment Congresses Cancer United States Prevention Congresses Health planning United States Congresses USA Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=444959 |
| work_keys_str_mv | AT nationalcancerpolicyforumus facilitatingcollaborationstodevelopcombinationinvestigationalcancertherapiesworkshopsummary AT patlakmargie facilitatingcollaborationstodevelopcombinationinvestigationalcancertherapiesworkshopsummary AT nasssharylj facilitatingcollaborationstodevelopcombinationinvestigationalcancertherapiesworkshopsummary AT balogherin facilitatingcollaborationstodevelopcombinationinvestigationalcancertherapiesworkshopsummary AT instituteofmedicineusboardonhealthcareservices facilitatingcollaborationstodevelopcombinationinvestigationalcancertherapiesworkshopsummary |